NEW ORLEANS — In a new study, use of a wrist-worn sensor was clinically feasible for rapid, bloodless prediction of elevated troponin I in patients with suspected MI, researchers reported at the American College of Cardiology Scientific Session.“Assessing high-sensitivity cardiac troponin for chest pain is standard practice in crowded emergency rooms. Although point-of-care tests are
The complication rate was "one of the lowest ever reported in a catheter ablation trial." In all, the emerging technology s performance was at least comparable to standard RF ablation.
NEW ORLEANS — In the PULSED AF pivotal trial, pulsed field ablation of symptomatic atrial fibrillation yielded a low rate of adverse events and demonstrated effectiveness consistent with established ablation strategies at 1 year.Pulsed field ablation is a novel ablation technology that utilizes electrical pulses to treat AF.